353 related articles for article (PubMed ID: 35814833)
41. BAI1 acts as a tumor suppressor in lung cancer A549 cells by inducing metabolic reprogramming via the SCD1/HMGCR module.
Liu L; Chai L; Ran J; Yang Y; Zhang L
Carcinogenesis; 2020 Dec; 41(12):1724-1734. PubMed ID: 32255478
[TBL] [Abstract][Full Text] [Related]
42. Metabolic Signaling to Epigenetic Alterations in Cancer.
Kim JA; Yeom YI
Biomol Ther (Seoul); 2018 Jan; 26(1):69-80. PubMed ID: 29212308
[TBL] [Abstract][Full Text] [Related]
43. Metabolic Reprogramming of Colorectal Cancer Cells and the Microenvironment: Implication for Therapy.
Nenkov M; Ma Y; Gaßler N; Chen Y
Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34200820
[TBL] [Abstract][Full Text] [Related]
44. [Metabolic reprogramming in cancer: the art of balance].
Yi M; Xiang B; Li X; Li G
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2013 Nov; 38(11):1177-87. PubMed ID: 24316928
[TBL] [Abstract][Full Text] [Related]
45. 4-Hydroxyphenylpyruvate Dioxygenase-Like Protein Promotes Pancreatic Cancer Cell Progression and Is Associated With Glutamine-Mediated Redox Balance.
Ye X; Wei X; Liao J; Chen P; Li X; Chen Y; Yang Y; Zhao Q; Sun H; Pan L; Chen G; He X; Lyu J; Fang H
Front Oncol; 2020; 10():617190. PubMed ID: 33537239
[TBL] [Abstract][Full Text] [Related]
46. Recent advances in the role of AMP-activated protein kinase in metabolic reprogramming of metastatic cancer cells: targeting cellular bioenergetics and biosynthetic pathways for anti-tumor treatment.
Tyszka-Czochara M; Konieczny P; Majka M
J Physiol Pharmacol; 2018 Jun; 69(3):. PubMed ID: 30279304
[TBL] [Abstract][Full Text] [Related]
47. Redox tolerance and metabolic reprogramming in solid tumors.
Mortezaee K
Cell Biol Int; 2021 Feb; 45(2):273-286. PubMed ID: 33236822
[TBL] [Abstract][Full Text] [Related]
48.
Zhang W; Bouchard G; Yu A; Shafiq M; Jamali M; Shrager JB; Ayers K; Bakr S; Gentles AJ; Diehn M; Quon A; West RB; Nair V; van de Rijn M; Napel S; Plevritis SK
Cancer Res; 2018 Jul; 78(13):3445-3457. PubMed ID: 29760045
[TBL] [Abstract][Full Text] [Related]
49. Metabolomics analysis reveals Oct4 overexpression drives metabolic reprogramming and enhanced glycolysis and pentose phosphate pathway in lung adenocarcinoma cells.
Tang Y; Zhu L; Chen H; Meng S
Biomed Chromatogr; 2022 Jun; 36(6):e5367. PubMed ID: 35274324
[TBL] [Abstract][Full Text] [Related]
50. Metabolic Reprogramming and Epithelial-Mesenchymal Plasticity: Opportunities and Challenges for Cancer Therapy.
Sun NY; Yang MH
Front Oncol; 2020; 10():792. PubMed ID: 32509584
[TBL] [Abstract][Full Text] [Related]
51. TLR-mediated metabolic reprogramming in the tumor microenvironment: potential novel strategies for cancer immunotherapy.
Huang L; Xu H; Peng G
Cell Mol Immunol; 2018 May; 15(5):428-437. PubMed ID: 29553135
[TBL] [Abstract][Full Text] [Related]
52. FRK plays an oncogenic role in non-small cell lung cancer by enhancing the stemness phenotype via induction of metabolic reprogramming.
Zhang L; Yang Y; Chai L; Bu H; Yang Y; Huang H; Ran J; Zhu Y; Li L; Chen F; Li W
Int J Cancer; 2020 Jan; 146(1):208-222. PubMed ID: 31251822
[TBL] [Abstract][Full Text] [Related]
53. Participation of protein metabolism in cancer progression and its potential targeting for the management of cancer.
Liu D; Wang Y; Li X; Wang Y; Zhang Z; Wang Z; Zhang X
Amino Acids; 2023 Oct; 55(10):1223-1246. PubMed ID: 37646877
[TBL] [Abstract][Full Text] [Related]
54. Metabolic Reprogramming of Myeloid-derived Suppressor Cells in the Tumor Microenvironment.
Liu L; Huo S; Liu J; Li Q; Wang J
Discov Med; 2021; 31(164):141-146. PubMed ID: 35188888
[TBL] [Abstract][Full Text] [Related]
55. The role of metabolic reprogramming in kidney cancer.
Chen Z; Zhang X
Front Oncol; 2024; 14():1402351. PubMed ID: 38884097
[TBL] [Abstract][Full Text] [Related]
56. HIF-1α switches the functionality of TGF-β signaling via changing the partners of smads to drive glucose metabolic reprogramming in non-small cell lung cancer.
Huang Y; Chen Z; Lu T; Bi G; Li M; Liang J; Hu Z; Zheng Y; Yin J; Xi J; Lin Z; Zhan C; Jiang W; Wang Q; Tan L
J Exp Clin Cancer Res; 2021 Dec; 40(1):398. PubMed ID: 34930376
[TBL] [Abstract][Full Text] [Related]
57. Exosome-mediated metabolic reprogramming: the emerging role in tumor microenvironment remodeling and its influence on cancer progression.
Yang E; Wang X; Gong Z; Yu M; Wu H; Zhang D
Signal Transduct Target Ther; 2020 Oct; 5(1):242. PubMed ID: 33077737
[TBL] [Abstract][Full Text] [Related]
58. Metabolic exchanges within tumor microenvironment.
Chiarugi P; Cirri P
Cancer Lett; 2016 Sep; 380(1):272-80. PubMed ID: 26546872
[TBL] [Abstract][Full Text] [Related]
59. Perspectives of Reprogramming Breast Cancer Metabolism.
Wang YP; Lei QY
Adv Exp Med Biol; 2017; 1026():217-232. PubMed ID: 29282686
[TBL] [Abstract][Full Text] [Related]
60. Metabolic reprogramming in colorectal cancer: regulatory networks and therapy.
Zhang J; Zou S; Fang L
Cell Biosci; 2023 Feb; 13(1):25. PubMed ID: 36755301
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
